Document Type : Original Article
Authors
1
Department of Community Medicine and Public Health Sciences, LUMHS, Pakistan
2
College of Pharmacy, Liaquat University of Medical and Health Sciences Jamshoro, Pakistan
3
Kings College Hospital London. United Kingdom.
4
Peoples University of Medical And Health Sciences for Women, Nawabshah, Pakistan
Abstract
Background: Diseases of the ear, nose, and throat (ENT) are among the most prevalent illnesses impacting the global population. Tonsillitis, otitis media, pharyngitis, nasopharyngitis, and other common ENT diseases are known as acute respiratory infections (ARI). Summary: ARI is responsible for roughly 30% of consultations in all patients and 25% of hospitalization in children, according to the World Health Organization (WHO). Antibiotics are commonly used to treat ENT diseases, and the antibiotic prescribing pattern is critical in terms of patient safety, disease management, and cost-effectiveness. Tonsillitis is an inflammation of the tonsils with signs and symptoms including Sore throat, fever, tonsil enlargement, difficulty gulping, and large lymph hubs around the neck are all possible side effects. Acute tonsillitis is treated with different groups of antibiotics including Penicillin followed by Cephalosporin, Macrolide, Fluoroquinolones, and Sulfonamides. β-hemolytic Streptococci, coagulase-positive Staphylococci, Pneumococci, and coagulase-positive Staphylococci and Pneumococci are most commonly isolated microorganisms from acute tonsillitis patients. Key messages: Antibiotic prescribing patterns that are irrational are widely documented across the world, and it is one of the biggest health concerns when it comes to patient safety. Increased irrational prescribing causes patients to develop drug resistance, as well as adverse drug reactions (ADRs) and higher therapy costs.
Keywords
)
View on SCiNiTO